Armistice Capital, LLC Neuro Sense Therapeutics Ltd. Call Options Transaction History
Armistice Capital, LLC
- $7.69 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
8Shares Held
1.67MCall Options Held
0Put Options Held
0-
Meitav Dash Investments LTD40KShares$54,0000.0% of portfolio
-
Xtx Topco LTD London, X032.7KShares$44,0770.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$16,1500.0% of portfolio
-
Morgan Stanley New York, NY1.5KShares$2,0250.0% of portfolio
-
Cwm, LLC1KShares$1,3500.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $15.8M